In addition, activation of the RASAL2/ARHGAP24/RAC1 module slows triple-negative breast cancer (TNBC) progression [19], and RASAL2 overexpression is related to poor prognosis and tumor recurrence in TNBC. Here, RASAL2 is linked to neoplasm.